JVMIX
Price
$29.59
Change
-$0.39 (-1.30%)
Updated
Nov 13 closing price
Net Assets
24.25B
TOTFX
Price
$11.47
Change
-$0.04 (-0.35%)
Updated
Nov 13 closing price
Net Assets
929.61M
Interact to see
Advertisement

JVMIX vs TOTFX

Header iconJVMIX vs TOTFX Comparison
Open Charts JVMIX vs TOTFXBanner chart's image
JHancock Disciplined Value Mid Cap I
Price$29.59
Change-$0.39 (-1.30%)
VolumeN/A
Net Assets24.25B
Transamerica Mid Cap Value Opps R4
Price$11.47
Change-$0.04 (-0.35%)
VolumeN/A
Net Assets929.61M
JVMIX vs TOTFX Comparison Chart in %
View a ticker or compare two or three
VS
JVMIX vs. TOTFX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMIX is a Hold and TOTFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 24.2B vs. TOTFX (930M). TOTFX pays higher dividends than JVMIX: TOTFX (1.26) vs JVMIX (0.75). JVMIX was incepted earlier than TOTFX: JVMIX (28 years) vs TOTFX (9 years). TOTFX (0.99) is less costly to investors than JVMIX (0.86). JVMIX (49.00) and TOTFX (48.00) have comparable annual turnover. TOTFX has a lower initial minimum investment than JVMIX: TOTFX (5000) vs JVMIX (250000). TOTFX annual gain was more profitable for investors over the last year : -4.70 vs. JVMIX (-6.53). JVMIX return over 5 years is better than : 36.37 vs. TOTFX (2.79).
JVMIXTOTFXJVMIX / TOTFX
Total Expense Ratio0.850.9094%
Annual Report Gross Expense Ratio0.860.9987%
Fund Existence28 years9 years-
Gain YTD9.7966.970141%
Front LoadN/AN/A-
Min. Initial Investment25000050005,000%
Min. Initial Investment IRAN/AN/A-
Net Assets24.2B930M2,602%
Annual Yield % from dividends0.751.2660%
Returns for 1 year-6.53-4.70139%
Returns for 3 years15.242.32656%
Returns for 5 years36.372.791,305%
Returns for 10 years50.51N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX4.230.13
+3.17%
CytomX Therapeutics
BTCS2.980.05
+1.71%
BTCS
FWONA92.520.10
+0.11%
Liberty Media Corp
CLRB3.50-0.06
-1.69%
Cellectar Biosciences Inc
TENB27.51-0.54
-1.93%
Tenable Holdings